More than 80 scientists from 50 institutions worldwide were collaborating in the CIAO project !
Watch their testimony in our video "Time to say CIAO to each other"
Disclaimer. The project was solely associated with individual scientist participation and their own expressions of interest and opinions, it does not represent the official position of any institutions.
​​
The work within the project was organized among working groups and teams focusing on the different outcomes of the disease and on the different aspects of the project.
The collaboration of the CIAO crowd was governed by our Ground Rules, which can be downloaded here.
The CIAO co-ordination team provided steering to the project, manages activities, organises workshops, disseminates outputs.
Penny Nymark
Institute of Environmental Medicine, Karolinska Institute
Sweden
Eftychia Lekka
Biovista
Greece, Europe
Annamaria Carusi
Interchange Research
United Kingdom
Steve Edwards
RTI
United States of America
Vassilis Virvilis
Biovista
Greece, Europe
Maria João Amorim
Instituto Gulbenkian de Ciência
Portugal
Julija Filipovska
Independent
North Macedonia
Natalia Garcia-Reyero Vinas
ERDC
United States of America
The Hub-Lung AOP group focused on developing KEs common to multiple COVID-19 outcomes (e.g. coagulation, hyperinflammation) jointly with developing pulmonary AOPs.
Penny Nymark
Institute of Environmental Medicine, Karolinska Institute
Sweden
Maria João Amorim
Instituto Gulbenkian de Ciência
Portugal
Adrienne Layton
Independent,
United States of America
Anil Hormis
Sheffield Hallam University United Kingdom
Dania Movia
Trinity College Dublin
Irelan
Daniel Jacobson
Oak Ridge National Laboratory
United States of America
Dario Greco
Helsinki Institute for Life Sciences
Finland
Felicity Gavins
Brunel University London
United Kingdom - Europe
Gillina Bezemer
Impact Station - University of Utrecht
The Netherlands- Europe
Giusy del Giudice
Helsinki Institute for Life Sciences
Finland - Europe
Holly Mortensen
EPA
United States of America
Huynjoon Kong
University of Illinois
United States of America
Ian Choi
Korea Institute of Science and Technology Europe FmbH
Germany
Jennifer Waspe
Sheffield Hallam University United Kingdom
Jorid Sørli
The National Research Centre for the Working Environment
Danemark
Joshua Breidenbach
University of Toledo
United States of America
Julija Filipovska
Independent
North Macedonia
Katherina Sewald
Fraunhofer ITEM
Germany
Katya Tsaioun
Johns Hopkins Bloomberg
United States of America
Laura Saarimaki
Helsinki Institute for Life Sciences
Finland
Luigi Margiotta-Casaluci
Brunel University London
United Kingdom
Marvin Martens
Maatstricht University,
The Netherlands
​
​
Merlin Mei
EPA
United States of America
Rik de Swart
University of Wageningen
the Netherland
Sabina Hallapanavar
Health Canada
Canada
Sally Mayasich
US EPA
Unitesd States of America
Shihori Tanabe
National Institute of Health Sciences
Japan
​
Youngjun Kim
KIST Europe
Germany
The Neuro AOP group focused on developing AOPs and KEs linked to neuropathological conditions (anosmia, seizures, epilepsy, encephalitis, …) -
Helena Hogberg
Johns Hopkins University
United States of America
Alan Hargreaves
Nottingham Trent University
United Kingdom
Francesca deBernardi
Ospedale Varese
Italy
Muhammad Ali Shahbaz
University of Eastern Finland
Finland
Natalia Garcia-Reyero Vinas
ERDC
United States of America
Surat Saravanan
HSI
India
The Multi-Organ group and Gut sub-group focused on developing AOPs specific to liver, kidney, heart and gut
Maria Cristina Albertini
Universita degli Studi di Urbino Carlo Bo
Italy - Europe
Julija Filipovska
Independent
North Macedonia
Daniel Jacobson
Oak Ridge National Laboratory
United States of America
Natalia Garcia-Reyero Vinas
ERDC
United States of America
Lucia Grenga
CEA, Paris
France
​
Mathieu Vinken
Vrije Universiteit Brussel
Belgium
Mauro Petrillo
Seidor
Italy
The Modulating factors group focused on integrating modulating factors into KEs/KERs/AOP
Alberto Mantovani
Istituto Superiore di Sanita
Italy
Alicia Paini
EqsLab
Germany
Mauro Petrillo
Seidor
Italy
Anna Beronius
Institute of Environmental Medicine, Karolinska Institute
Sweden - Europe
Daniel Jacobson
Oak Ridge National Laboratory
United States of America
Elma Omeragic
University of Sarajevo
Bosnia and Herzegovina
Gillina Bezemer
Impact Station - University of Utrecht
The Netherlands- Europe
Giusy del Giudice
Helsinki Institute for Life Sciences
Finland - Europe
Helena Soares
Universidade Nova de Lisboa
Portugal
Maria Cristina Albertini
Universita degli Studi di Urbino Carlo Bo
Italy - Europe
Mylene Huynh
TruPoint Health
United States of America
Nuria Amigo Grau
Biosfer Teslab
Spain
Laura Saarimaki
Helsinki Institute for Life Sciences
Finland - Europe
The literature review group explored how to apply systematic literature review to support AOP development (neuro pilot study)
Alan Hargreaves
Nottingham Trent University
United Kingdom
Helena Hogberg
Johns Hopkins University
United States of America
Jennifer Waspe
Sheffield Hallam University United Kingdom - Europe
Elma Omeragic
University of Sarajevo
Bosnia and Herzegovina
Joshi Ojasi
University of Mumbai
India
Natalia Garcia-Reyero Vinas
ERDC
United States of America
Joshua Breidenbach
University of Toledo
United States of America
Julija Filipovska
Independent
North Macedonia - Europe
Katya Tsaioun
Johns Hopkins Bloomberg
United States of America
Rebecca Elmore
Sciome
United States of America
Rebecca Ram
Safer Medicines Trust
United Kingdom
Shannon Plant
University of Sussex
United Kingdom
Ishita Virmani
Johns Hopkins University
United States of America
The CIAO ontology team aimed to work on ontology harmonization of the CIAO AOPs to allow ideal network visualization
Christos Andronis
Biovista
Greece, Europe
Eftychia Lekka
Biovista
Greece, Europe
Steve Edwards
RTI
United States of America
Vassilis Virvilis
Biovista
Greece, Europe
Penny Nymark
Institute of Environmental Medicine, Karolinska Institute
Sweden - Europe
Merlin Mei
EPA
United States of America
Ian Choi
Korea Institute of Science and Technology Europe FmbH
Germany - Europe
Marvin Martens
Maatstricht University,
The Netherlands, Europe
Laura Saarimaki
Helsinki Institute for Life Sciences
Finland - Europe
Julija Filipovska
Independent
North Macedonia - Europe
Andreas Persidis
Biovista
Greece, Europe
The multiscale impact group aimed to elucidate the multiscale factors of COVID-19 across levels and time and evolve the AOPs to address those multiscale aspects.